Two new immunisation programmes launched in the UK in 2015
MENACWY for teenagers
A virulent strain of MenW is causing meningitis and septicaemia across all age groups especially babies, healthy teenagers and young adults and has a higher death rate associated with it than other strains of meningococcal disease.
A programme to immunise everyone aged 14-18 years of age is now being implemented in order to generate herd protection against MenW and prevent further rapid increases in disease amongst the rest of the population. Both conjugate MenACWY vaccines, Menveo and Nimenrix, can be used for this programme.
We have launched #StoptheSpread, a campaign to raise awareness of the importance of vaccination amongst school children and first year university students.More about our #StopTheSpread campaign Read more about the rise in MenW diseaseMore in depth information on MenACWY vaccine implementation
Information and training slides for immunisers have been produced by Public Health England:
MenB vaccine - Bexsero
Read our comprehensive Men B vaccine factsheetProphylactic paracetamol use
- The new MenB vaccine has been available to all UK babies as part of the routine immunisation schedule from 1 September 2015
- All babies born on or after 1 May 2015 are also eligible for the vaccine on the NHS
- Babies born before 1 May 2015 will not be offered the vaccine on the NHS, but it is available privately for older children.*
*Shortage in Private supply of Bexsero
- Clinical trials of the MenB vaccine Bexsero found that rates of fever after administering Bexsero alongside other childhood immunisations are higher than when existing routine vaccines are given alone. There was a 51-61% fever rate after Bexsero was given alongside routine vaccines compared to 23-36% after routine vaccines alone.
- To reduce the likelihood of fever it is recommended that three doses of prophylactic paracetamol be given to children with the MenB doses in infancy (at the 2 and 4 month visits)
- The first dose of paracetamol should be given at the time of vaccination or as soon as possible afterwards and the second and third doses should be given at 4-6 hourly intervals thereafter.
- For a limited time infant paracetamol sachets were made available for practices to order centrally but these are no longer available to order from the Immform website. Parents should be advised to purchase a bottle of infant paracetamol on their way home if they don’t have some at home already, and to give the first dose to their baby as soon as they can.
- Parents should also be given the “Using paracetamol to prevent and treat fever after MenB vaccination” leaflet at the two and four month appointment visits. Hard copies can be ordered from the following link https://www.orderline.dh.gov.uk/ecom_dh/public/home.jsf
There has been a shortage in the supply of Bexsero for the private market during the first half of 2016. This means that patients with children born prior to 1 May 2015 who wish to obtain the vaccine privately for the first time will need to delay starting their immunisation course until the summer.
GSK have released the following statement about this:“Due to unexpected global demand for Bexsero during 2015, we are experiencing supply constraints during the first half of this year.
Although vaccination through the NHS childhood programme has been prioritised and is unaffected, we have unfortunately had to ask private clinics temporarily to not start new courses of vaccination. Children who have already started their course of the vaccine privately should still be able receive their follow up doses.
We know the unexpectedly high demand for the vaccine reflects the importance parents have placed on protecting their children from meningitis B, so we are working hard to increase supply, and expect to have increased stock by summer 2016.” More in depth information on MenB vaccine implementation
Information and training slides for immunisers have been produced by Public Health England